Quantcast

FDA Links Topamax® to Birth Defects

May 15, 2011

The U.S. Food and Drug Administration (FDA) links Topamax® to cleft lip and cleft palate.

Houston, Texas (PRWEB) May 13, 2011

The U.S. Food and Drug Administration (FDA) notified healthcare professionals and patients of a link between Topamax® (topiramate) and birth defects on March 4, 2011. Moulton & Arney, a litigation firm, is sponsoring TopamaxCleftLipLawyer.com, an online resource that aims to provide useful information about the Topamax® birth defect risk.

“The evidence reported by the FDA establishes a very troubling connection between Topamax® use by pregnant women and oral clefts in their babies,” said Cynthia Moulton an attorney at Moulton & Arney. “We intend to help families affected by these birth defects obtain compensation for injuries to their babies shown to be caused by Topamax®.”

Topamax® is used as a seizure prevention medication for certain patients with epilepsy. It is also prescribed to prevent migraine headaches. According to the FDA alert, babies that are exposed to the drug during fetal development have a greater risk of developing cleft lip and/or cleft palate.

Cleft lip and cleft palate are oral and facial abnormalities that can affect a child’s ability to eat and speak properly. The defects can also cause dental problems and hearing loss.

The FDA based its warning on data from the North American Antiepileptic Drug (NAAED) Pregnancy Registry. According to the data, infants whose mothers take Topamax® during their pregnancy have a much higher risk of developing oral clefts than those who are exposed to other epilepsy medications or no anti-seizure medications at all.

The FDA encourages women of childbearing age to take birth control while using the medication and to speak with their doctors about safer alternatives if they become pregnant or are thinking about becoming pregnant.

Cleft lip and cleft palate are treatable through surgery, but in the more severe cases, it can take years and multiple surgeries to achieve a normal appearance and speech.

In addition to surgery, affected children might also require speech therapy, dental work, treatments for ear infections, and therapy for the emotional effects of having a facial defect.

TopamaxCleftLipLawyer.com is an online resource that provides information and resources for families that have been affected by Topamax® birth defects. It was created to spread awareness about the potential dangers of the medication and to help infants and parents that have already been impacted seek and obtain compensation for their present and future medical bills, cost of treatment, and pain and suffering.

For more information about pursuing a Topamax® birth defect case, or to schedule a private and free consultation with a birth defect lawyer, call 1-800-701-2406.

# # #

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebtopamax/cleft-lip/prweb8425343.htm


Source: prweb



comments powered by Disqus